Rekah Pharmaceutical Industry Ltd (REKA) — Net Asset Momentum
Rekah Pharmaceutical Industry Ltd (REKA) recorded a net asset momentum of -11.0% as of December 2025, with net assets of ILA144.21 Million ILA. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Rekah Pharmaceutical Industry Ltd (REKA) defensive interval to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Rekah Pharmaceutical Industry Ltd Net Asset Momentum (2004–2025)
This chart tracks Rekah Pharmaceutical Industry Ltd's year-over-year net asset growth across 22 annual reporting periods from 2004 to 2025. The most recent momentum reading is -11.0%, with net assets of ILA144.21 Million ILA as of December 2025. Read Rekah Pharmaceutical Industry Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Rekah Pharmaceutical Industry Ltd (2004–2025)
The table below shows the complete annual net asset history for Rekah Pharmaceutical Industry Ltd from 2004 to 2025, covering 22 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market value of Rekah Pharmaceutical Industry Ltd.
| Year | Net Assets (ILA) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | ILA144.21 Million | ILA423.68 Million | ILA279.47 Million | ▼ -11.0% |
| 2024 | ILA161.98 Million | ILA447.22 Million | ILA285.24 Million | ▲ +4.1% |
| 2023 | ILA155.59 Million | ILA484.72 Million | ILA329.14 Million | ▼ -4.0% |
| 2022 | ILA162.08 Million | ILA448.42 Million | ILA286.34 Million | ▼ -6.3% |
| 2021 | ILA173.06 Million | ILA437.09 Million | ILA264.02 Million | ▲ +4.5% |
| 2020 | ILA165.59 Million | ILA419.69 Million | ILA254.10 Million | ▲ +6.7% |
| 2019 | ILA155.22 Million | ILA367.11 Million | ILA211.89 Million | ▲ +3.0% |
| 2018 | ILA150.66 Million | ILA300.28 Million | ILA149.62 Million | ▲ +4.2% |
| 2017 | ILA144.62 Million | ILA294.95 Million | ILA150.33 Million | ▲ +36.6% |
| 2016 | ILA105.86 Million | ILA322.72 Million | ILA216.86 Million | ▼ -14.4% |
| 2015 | ILA123.66 Million | ILA323.82 Million | ILA200.17 Million | ▲ +60.5% |
| 2014 | ILA77.06 Million | ILA310.11 Million | ILA233.05 Million | ▼ -3.1% |
| 2013 | ILA79.51 Million | ILA303.16 Million | ILA223.65 Million | ▲ +11.7% |
| 2012 | ILA71.17 Million | ILA298.07 Million | ILA226.90 Million | ▲ +11.2% |
| 2011 | ILA64.00 Million | ILA286.99 Million | ILA222.98 Million | ▲ +0.3% |
| 2010 | ILA63.78 Million | ILA287.97 Million | ILA224.18 Million | ▼ -0.6% |
| 2009 | ILA64.15 Million | ILA278.40 Million | ILA214.25 Million | ▲ +9.4% |
| 2008 | ILA58.62 Million | ILA290.50 Million | ILA231.87 Million | ▼ -12.6% |
| 2007 | ILA67.10 Million | ILA300.96 Million | ILA233.86 Million | ▲ +9.0% |
| 2006 | ILA61.54 Million | ILA296.53 Million | ILA234.99 Million | ▲ +4.6% |
| 2005 | ILA58.85 Million | ILA267.00 Million | ILA208.15 Million | ▲ +20.4% |
| 2004 | ILA48.86 Million | ILA202.04 Million | ILA153.18 Million | — |